Section Arrow
Quote
BVS.NASDAQ
- Bioventus
Quotes are at least 15-min delayed:2025/01/21 05:29 EST
Last
 10.04
-0.07 (-0.69%)
Day High 
10.25 
Prev. Close
10.11 
1-M High
11.59 
Volume 
370.17K 
Bid
9.5
Ask
12.27
Day Low
9.85 
Open
10.15 
1-M Low
8.77 
Market Cap 
660.87M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 9.72 
20-SMA 10.21 
50-SMA 11.06 
52-W High 14.38 
52-W Low 3.9 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.61/1.00
Enterprise Value
1.03B
Balance Sheet
Book Value Per Share
2.28
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
512.35M
Operating Revenue Per Share
7.69
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
QSIQuantum-Si2.24-0.3-11.81%-- 
SENSSenseonics Holdings0.8479-0.0271-3.10%-- 
BDMDBaird Medical Investment Holdings Ltd8.85+3.43+63.28%15.32PE
BMRABiomerica0.64-0.066-9.35%-- 
MDTMedtronic plc88.08+0.92+1.06%26.61PE
Quotes are at least 15-min delayed：2025/01/21 05:29 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.